Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy

6 Jul 2023

Abstract excerpt

Harnessing the immune system to combat disease has revolutionized medical treatment. Monoclonal antibodies (mAbs), in particular, have emerged as important immunotherapeutic agents with clinical relevance in treating a wide range of diseases, including allergies, autoimmune diseases, neurodegenerative disorders, cancer, and infectious diseases. These mAbs are developed from naturally occurring antibodies and...

Topics

Join the communities discussing this publication.

CAR-T cell therapy research
Immunotherapy and Immune Responses
Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37489368
DOI: 10.3390/antib12030046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in ImmunotherapyPMID 37489368Read ↗

Monoclonal antibodies: From magic bullet to precision weaponSemantic proximity Read ↗

A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current ApplicationsSemantic proximity Read ↗

DNA immunization as a technology platform for monoclonal antibody inductionSemantic proximity Read ↗

Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeuticsSemantic proximity Read ↗

Therapeutic Applications of AptamersSemantic proximity Read ↗

Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid deliverySemantic proximity Read ↗

Anti-Idiotypic mRNA Vaccine to Treat Autoimmune DisordersSemantic proximity Read ↗

Therapeutic antibodies for human diseases at the dawn of the twenty-first centurySemantic proximity Read ↗

Nanomedicine for Cancer and Autoimmune ImmunotherapySemantic proximity Read ↗

Structure and sequence engineering approaches to improve in vivo expression of nucleic acid-delivered antibodies.Semantic proximity Read ↗

Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologicsSemantic proximity Read ↗

Clinical Applications of Single-Stranded Oligonucleotides: Current Landscape of Approved and In-Development TherapeuticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.